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study question: How does maternal cigarette smoking disturb development of the human fetal ovary?
summaryanswer: Maternal smoking increases fetal estrogen titres and dysregulates several developmental processes in the fetal ovary.
what is knownalready: Exposure tomaternal cigarette smokingduring gestation reduceshuman fetalovariancell numbers, germcell
proliferation and subsequent adult fecundity.
study design, size, duration: The effects ofmaternal cigarette smoking on the second trimester human fetal ovary, fetal endocrine
signalling and fetal chemical burdenwere studied.A total of 105 fetuseswere studied, 56 frommotherswhosmokedduringpregnancyand49 from
those who did not.
participants/materials, settingmethods:Ovary, liverandplasma sampleswerecollected fromelectively terminated, nor-
mally progressing, second trimester human fetuses.Circulating fetal hormones, levelsof 73 fetal ovarian transcripts, protein localization, densityof
oocytes/primordial follicles and levels of 16 polycyclic aromatic hydrocarbons (PAHs) in the fetal liver were determined.
main results and the role of chance: Circulating fetal estrogen levels were very high andwere increased bymaternal smoking
(ANOVA, P ¼ 0.055–0.004 versus control). Smokeexposure also dysregulated (two-wayANOVA, smoking versus gestationweeks interaction,
P ¼ 0.046–0.023) four fetal ovarian genes (cytochrome P450 scc [CYP11A1], NOBOX oogenesis homeobox [NOBOX], activator of apoptosis
harakiri [HRK], nuclear receptor subfamily 2, group E,member 1 [NR2E1]), shifted the ovarian InhibinbA/inhibina ratio (NHBA/INHA) transcript
ratio in favour of activin (ANOVA, P ¼ 0.049 versus control) and reduced the proportion of dominant-negative estrogen receptor 2 (ERb: ESR2)
isoforms in half the exposed fetuses. PAHs, ligands for the aryl hydrocarbon receptor (AHR), were increased nearly 6-fold by maternal smoking
(ANOVA, P ¼ 0.011 versus control). A fifth transcript, COUP transcription factor 1 (nuclear receptor subfamily 2, group F, member 1:NR2F1,
which contains multiple AHR-binding sites), was both significantly increased (ANOVA, P ¼ 0.026 versus control) and dysregulated by (two-way
ANOVA, smoking versus gestationweeks interaction,P ¼ 0.021)maternal smoking.NR2F1 is associatedwith repressionof FSHRexpression and
smoke-exposed ovaries failed to show the normal increase in FSHR expression during the second trimester. There was a significantly higher
number of DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 (DDX4) VASA-positive (ANOVA, P ¼ 0.016 versus control), but not POU domain,
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class 1, transcription factor 1 (POU5F1)OCT3/4-positive, oocytes in smoke-exposed fetuses and thismatchedwith a significantly higher number
of primordial follicles (ANOVA, P ¼ 0.024 versus control).
limitations, reasons for caution: The effects of maternal smoking on establishment of the maximum fetal primordial follicle
pool cannot be reliably studied in our population since the process is not completed until 28 weeks of gestation and normal fetuses older than
21 weeks of gestation are not available for study. Our data suggest that some fetal ovaries are affected by smoke exposure while others are
not, indicating that additional studies, with larger numbers, may show more significant effects.
wider implications of the findings: Fetal exposure to chemicals in cigarette smoke is known to lead to reduced fecundity in
women. Our study suggests, for the first time, that this occurs via mechanisms involving activation of AHR, disruption of inhibin/activin and es-
trogen signalling, increased exposure to estrogen and dysregulation of multiple molecular pathways in the exposed human fetal ovary. Our data
also suggest that alterations in the ESR2 positive and dominant negative isoforms may be associated with reduced sensitivity of some fetuses to
increased estrogens and maternal smoking.
study funding/competing interest(s): The studywas supported by grants fromtheChief ScientistOffice (Scottish Executive,
CZG/1/109, and CZG/4/742), NHS Grampian Endowments (08/02), the European Community’s Seventh Framework Programme (FP7/
2007-2013) under grant agreement no. 212885, a Society for Reproduction & Fertility summer studentship,Medical Research Scotland (research
grant 354 FRG) and the Medical Research Council (WBS: U.1276.00.002.00001 and G1100357). The authors declare they have no competing
interests, be it financial, personal or professional.
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Introduction
Maternal cigarette smoking has wide-ranging harmful effects on fetal de-
velopment and the health of subsequent offspring. These effects include
reduced growth (Harvey et al., 2007), reduced academic achievement
(Birney et al., 2006), increased likelihood of metabolic syndrome
(Chen et al., 2006) and reproductive abnormalities and reduced fertility
(Weinberg et al., 1989; Jensen et al., 1998, 2006, 2007; Ramlau-Hansen
et al., 2007;Werler, 2007; Ye et al., 2010). The incidence of smoking has
generally fallen over the last 20 years but significant numbers of women
continue to smoke before and during pregnancy (Tong et al., 2009).
In Scotland, 31% of women are smokers when first pregnant (Prabhu
et al., 2010) and fewer than 4% of these will stop smoking (Tappin
et al., 2010). Smoke exposure in utero remains, therefore, a major
causeof adult ill-health and it is essential thatweunderstand themechan-
isms leading to altered fetal and post-natal development.
Primordial follicle formation is the single most important event in
establishing potential adult fecundity and the timing of menopause in
women (Laissue et al., 2008). In mice, primordial follicle numbers are
reduced by exposure to cigarette smoke (Tuttle et al., 2009), an effect
probably mediated by various chemicals, especially polycyclic aromatic
hydrocarbons (PAHs), in the smoke (Jurisicova et al., 2007). PAHs are
activating ligands for the aryl hydrocarbon receptor (AHR) and are
amongst the active compounds known to affect female reproductive de-
velopment in rodents (Matikainen et al., 2001).We have also shown that
the fetal human ovary expresses the AHR, its nuclear translocator
(ARNT) and that activating the AHR in the human fetal ovary in vitro sig-
nificantly reduces germ cell proliferation (Anderson et al., 2014). This
highlights a potential mechanism by which maternal smoking may affect
female reproductive development but which requires further study.
Many women delay childbirth to 35–40 years of age, at which point
they will be left with only 5% of their original reserve of non-growing
follicles (Wallace and Kelsey, 2010). It is likely, therefore, that reduced
fertility associated with in utero smoke exposure, when combined with
delayed childbirth, will result in a significant decline in conception rate.
Given the prevalence of maternal smoking and the exposure of preg-
nant women to awide range of environmental chemicals, it is critical that
we understand the effects of in utero exposure to chemicals in cigarette
smoke on the formation of human primordial follicles (from 18
weeks of gestation onwards (Fowler et al., 2009a)). We report here
that maternal smoking increases the exposure of the female fetus to
PAHs, increases fetal circulating estrogens and dysregulates ovarian de-
velopment and paracrine/endocrine signalling. The evidence suggests
that these effects may be mediated through induction of AHR pathways
and AHR-estrogen receptor (ESR) crosstalk.
Materials andMethods
Sample collection and study design
The collection of fetal material (Fowler et al., 2008) was approved by the
National Health Service Grampian Research Ethics Committees (REC 04/
S0802/21). Women seeking elective, medical terminations of pregnancy
were recruited with written, informed consent. Only normally progressing
pregnancies from women over 16 years of age and between 11 and 21
weeks of gestation were collected. Fetal ovaries were: (i) snap-frozen and
stored at 2858C, (ii) processed for histology or (iii) processed for in vitro
culture. The fetal livers were snap-frozen and stored at 2858C. In total,
105 female fetuses were included in this study, 56 from mothers who
smoked during pregnancy and 49 from those who did not. Circulating hor-
mones were assayed in a subset of 45 fetuses, with sufficient cardiac
blood, and, in a further subset of 22 fetuses, the ovarian expression levels
of key developmental genes were determined and liver PAH content mea-
sured. In 10 fetuses around 19 weeks of gestation circulating estrogens
were measured while 3 further fetuses, from non-smoking mothers, were
used for ovary culture to determine ovarian estrogen production (Tables I,
II and III, Figs 1 and 2). The remaining 25 fetuses contributed to the overall
assessment of smoke exposure effects on growth.
Hormone and cotinine assays
LH, FSH, prolactin (PRL) and intact hCG were measured using DELFIA kits
(Fowler et al., 2008, 2009a,b), with detection limits and inter- and intra-assay
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Table I Maternal cigarette smokingduring pregnancy does not significantly affect second trimester growthor pituitary hormoneprofile in the female human fetus
(mean+ SEM).
Measure All fetuses included Endocrine groupa qPCR/PAH groupa E1/E2 groupa,b Ovary
Control Smoke-exposed Control Smoke-exposed Control Smoke-exposed Control Smoke-exposed Culture group
n 5 49 n5 56 n5 19 n5 26 n5 10 n5 12 n5 5 n5 5 n5 3
Maternal characteristics
Age (years) 24.3+0.9 24.0+0.8 23+1 24+1 27+2 24+2 27.2+3.9 21.2+1.5 21.7+2.2
BMI (kg/m3) 24.2+0.6 24.7+0.7 24+1 24+1 26+2 25+2 24.8+2.1 27.3+3.5 25.7+1.9
Cigarettes per day 0 12+1 0 13+1 0 11+1 0 9+1 0
Fetal characteristics
Age (weeks) 14.9+0.3 14.9+0.3 16.1+0.6 15.6+0.5 15.4+0.8 14.9+0.8 18.6+0.2 19.2+0.4 17.0+0.6
Weight (g) 87.3+11.0 92.4+11.5 125+9 118+8 118+30 82+27 235+32 229+20 147.2+9.1
Crown-rump length (mm) 101.0+4.3 101.9+3.9 116+2 114+2 113+10 100+9 156+5 145+6 129.4+6.0
Ovary weight (mg) 14.4+1.8 14.4+2.2 23+3 19+2 18+5 16+4 34.6+3.6 35.8+7.6 30.6+2.5
Intact hCG (U/l) 106+33 133+29 148+82 169+71
LH (U/l) 48+5 51+4 44+10 51+9
FSH (U/l) 8+3 13+3 3+4 7+4
PRL (mU/l) 119+29 107+24 136+42 116+33
Cotinine (ng/ml)c 4+2 41+2 2+2 47+1 2+1 43+3 1+1 42+9 3+3
aThe quantitative PCR (qPCR)/polycyclic aromatic hydrocarbons (PAH) group includes some of the Endocrine group.
bTo enable 100 ml of plasma for analysis, only well characterized 18- and 19-week-old fetuses were used but not all had other endocrine data.
cFetal plasma cotinine significantly (P, 0.001) higher in smoke-exposed fetuses.
BM, body mass index; LH, lutenising hormone; FSH, follicle stimulating hormone; PRL, prolactin; E1/E2, estrone/estradiol.
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Table II Effects of maternal cigarette smoking on the mRNA transcript levels of 57 key genes in the human female fetal
ovary (mean+ SEM, based on the qPCR/ PAH group shown in Table I).
Gene
symbol
Gene product Controla Smoke-exposeda Two-way ANOVA
Smoking Weeks–smoke
interaction
n5 10 n 5 12 Pb Pb
Endocrine signalling: receptors
1. PGR Progesterone receptor 11.8+5.38 7.97+3.65 0.701 0.308
2. ESR1 Estrogen receptor a (ERa) 20.3+5.3 20.4+5.6 0.534 0.427
3. ESR2 ERb (all isoforms) 18.0+6.6 17.6+5.3 0.337 0.152
ERa/ERb ratio 1.44+0.17 1.28+0.12 0.354 0.154
4. ESR2 Estrogen receptor b dominant negative isoforms b and c 0.95+0.28 0.60+0.16 0.227 0.198
ESR2 a,d/b,c ratio (active/dominant negative ratio) 16.2+1.48 29.2+6.68 0.069 0.709
5. GPERc G-protein-coupled estrogen receptor 1 6.87+3.42 4.37+2.97 0.534 0.518
6. AR Androgen receptor 6.66+1.90 5.02+1.57 0.984 0.665
7. LHCGR LH/hCG receptor 0.07+0.04 0.02+0.02 0.279 0.169
8. FSHR FSH receptor 0.71+0.34 0.28+0.08 0.157 0.500
9. PRLR PRL receptor 0.93+0.21 0.66+0.19 0.719 0.715
10. ACVR1B Activin receptor type 1B 23.3+9.6 16.5+4.9 0.877 0.674
11. ACVR2A Activin receptor type 2A 21.8+8.6 15.3+5.1 0.756 0.124
Endocrine signalling: hormones
12. INHA Inhibin a 2.14+0.47 1.61+0.40 0.391 0.494
13. INHBA Inhibin bA 4.50+1.15 5.22+1.17 0.343 0.198
Inhibin bA/inhibin a ratio 2.23+ 0.40 3.78+ 0.52 0.049 0.453
14. INHBB Inhibin bB 0.35+0.15 0.43+0.12 0.451 0.834
Inhibin bB/inhibin a ratio 0.14+0.04 0.33+0.09 0.294 0.679
15. FST Follistatin 8.3+2.4 7.1+2.1 0.640 0.857
16. PROK2 Prokineticin 2 2.12+1.42 1.54+0.95 0.639 0.847
17. AMH Anti-Mullerian Hormone 0.03+0.01 0.07+0.05 0.617 0.900
Xenochemical signalling
18. AHR Arylhydrocarbon receptor 34.2+13.2 26.9+7.0 0.209 0.376
19. ARNT Arylhydrocarbon receptor nuclear translocator 32.0+9.02 25.5+6.73 0.606 0.374
AHR/ARNT ratio 0.90+0.12 1.07+0.21 0.123 0.057
Steroidogenesis
20. CYP11A1 Cytochrome P450 scc 6.16+ 2.02 4.13+ 1.14 0.912 0.035
21. CYP17A1 Cytochrome P450-C17 1.85+0.99 0.95+0.36 0.509 0.573
22. CYP19A1 Cytochrome P450 aromatase 16.0+4.5 10.3+2.3 0.383 0.270
23. STAR Steroid acute regulatory protein 4.25+0.96 3.55+0.62 0.862 0.116
24. HSD17B1 Hydroxysteroid (17-b) dehydrogenase 1 1.24+0.27 1.05+0.27 0.582 0.296
25. HSD17B3 Hydroxysteroid (17-b) dehydrogenase 3 0.10+0.04 0.06+0.02 0.193 0.335
26. HSD3B2 3 b-hydroxysteroid dehydrogenase/D54-isomerase type 2 0.67+0.25 0.31+0.10 0.340 0.103
27. STS Steroid sulfatase (microsomal), isozyme S 12.4+4.1 10.1+3.5 0.463 0.857
Wnt pathway signalling
28.WNT4 Wnt-4 1.81+0.33 2.23+0.48 0.542 0.325
29.WNT5A Wnt-5a 2.51+0.57 1.74+0.35 0.324 0.212
30.WNT6 Wnt-6 4.35+1.47 3.11+0.99 0.476 0.722
31.WNT9A Wnt-9a 0.26+0.13 0.16+0.09 0.905 0.905
32. FZD8 Frizzled-8 40.3+9.4 47.0+14.8 0.616 0.582
Continued
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coefficients of variation of 0.05 U LH/l, 2.4% and 4.2%, 0.5 U FSH/l, 2.8%
and 2.0%, 0.04 mU PRL/l, 2.0% and 3.0% and 0.5 U hCG/l, 4.1% and
4.6%, respectively. Cotinine, a marker of smoking, was measured using a
commercial kit (Cozart Plc, Abingdon, Kent, UK), with values of 0–12 ng
cotinine/ml being considered negative (Fowler et al., 2008). Fetal plasma
and ovary-conditioned culture medium samples were assayed for estrogens
by gas chromatography linked to mass spectrometry (GC-MS/MS).
The plasma preparation procedure (extraction and purification) used to
isolate the target steroids has been previously described (Courant et al.,
2007, 2010). Briefly, an enzymatic hydrolysis was followed by purification
and partitioning to separate androgens and estrogens. An Agilent 7890A
gas chromatograph coupled to a 7000 GC triple-quadrupole device
(Agilent, San Jose´, CA, USA) was used for analyte detection and quantifica-
tion in the selected reaction monitoring acquisition mode.
........................................
.............................................................................................................................................................................................
Table II Continued
Gene
symbol
Gene product Controla Smoke-exposeda Two-way ANOVA
Smoking Weeks–smoke
interaction
n5 10 n 5 12 Pb Pb
Transcription factor/regulation
33. FIGLA Factor in the germ-line a 9.13+5.27 6.46+3.84 0.175 0.108
34. FOXR1 Forkhead box protein R1 53.3+35.2 28.7+12.3 0.972 0.649
35. FOXL2 Forkhead box protein L2 144+60.5 99.0+36.7 0.232 0.786
36. SOHLH1 Spermatogenesis and oogenesis specific basic
helix-loop-helix-containing protein 1
4.66+3.34 2.34+1.08 0.297 0.282
37. LHX8 LIM/homeobox protein Lhx8 9.27+5.96 5.38+3.78 0.949 0.307
38.NR2E1 Nuclear receptor subfamily 2 group E member 1 2.00+ 1.14 1.71+ 0.89 0.007 0.046
39.NOBOX Homeobox protein NOBOX 14.5+ 8.1 11.4+ 6.8 0.125 0.023
40. POU5F1 POU domain, class 1, transcription factor 1 (OCT4) 272+65 473+139 0.123 0.462
41. SMAD2 Mothers against decapentaplegic homolog 2 19.7+5.4 16.3+4.5 0.774 0.196
Developmental gene
42. ZAR1 Zygote arrest protein 1 6.65+4.28 3.28+2.38 0.783 0.342
43. DDX4 DEAD box protein 4 (VASA) 94.6+38.4 88.7+31.5 0.447 0.257
44.MBNL1 Muscleblind-like, isoform CRA_f 66.4+20.5 57.8+15.6 0.778 0.161
45. CAPN3 Calpain 3 7.26+2.42 5.57+2.08 0.535 0.688
46. KIT Mast/stem cell growth factor receptor Kit (c-kit) 15.5+5.7 11.0+2.9 0.315 0.199
47. KITLG Kit ligand (SCF) 70.2+17.9 65.6+14.4 0.779 0.304
KIT/KITLG ratio 0.18+0.03 0.15+0.02 0.542 0.406
Protein/receptor binding/folding
48. HSPD1 Heat shock 60 kDa protein 95.0+27.9 91.7+27.8 0.297 0.105
49. NALP5 NACHT, LRR and PYD domains-containing protein 5 28.4+19.9 20.3+15.4 0.098 0.089
50. ZP2 Zona pellucida sperm-binding protein 2 8.94+6.68 2.09+1.47 0.637 0.325
51. ZPBP2 Zona pellucida-binding protein 2 30.8+20.4 17.1+7.53 0.825 0.938
52. NXPH1 Neuroexophillin-1 9.04+1.96 11.0+3.13 0.866 0.924
Apoptosis/proliferation/tumour suppression
53.HRK Activator of apoptosis harakiri 1.90+ 0.56 1.91+ 0.40 0.099 0.027
54. BAX Apoptosis regulator Bax 15.9+3.7 14.0+4.3 0.366 0.816
55. BCL2 Apoptosis regulator Bcl2 1.92+0.52 1.48+0.40 0.751 0.163
BAX:BCL2 ratio 10.6+1.9 14.8+6.3 0.560 0.360
56. PCNAc Proliferating cell nuclear antigen 23.9+14.4 26.1+11.7 0.877 0.674
57. PTEN Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and
dual-specificity protein phosphatase
172+83.6 112+47.1 0.945 0.966
Vault complex, nucleo-cytoplasmic transport, multidrug resistance
58.MVP Major vault protein (LRP, VAULT1) 22.8+6.0 19.5+4.0 0.627 0.306
aqPCR is expressed as mRNA relative to luciferase.
bStatistically significant P-values are shown in bold. Where relevant, multi-function genes are categorized according to their function most appropriate to ovarian development.
cTranscript expression below limit of detection in ≥50% of ovaries.
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Phenotypic investigationof smokingeffects on
the fetal ovary and immunohistochemistry
Ovarian sections (5 mm) were either stained with hematoxylin and eosin
(H&E) or using a Leica BOND-MAXTM automated immunostainer (Leica
Microsystems, Newcastle Upon Tyne, UK). The primary antibodies, all
with pH 6 antigen retrieval, were: (i) nuclear receptor subfamily 2 group E
member 1 (NR2E1): 2 mg/ml: rabbit polyclonal, Abcam (Cambridge, UK),
ab30942, (ii) activator of apoptosis harakiri (HRK): 1:50: goat polyclonal,
Santa Cruz Biotechnology (Santa Cruz, CA, USA), sc-6972, (iii) major vault
protein (MVP): 1:200: mouse monoclonal, Abcam, ab14562, (iv) POU
domain, class 1, transcription factor 1 (POU5F1, OCT4): 1:300, goat poly-
clonal, Santa Cruz, sc-8628, (v) DEAD (Asp-Glu-Ala-Asp) box polypeptide
4 (DDX4,VASA): 1:200: rabbit polyclonal,Abcam, ab13840, (vi)COUP tran-
scription factor 1 (nuclear receptor subfamily 2, group F,member 1:NR2F1):
1:2000: rabbit polyclonal, Abcam, ab96846, (vii) COUP transcription factor
2 (nuclear receptor subfamily 2, group F,member 2:NR2F2): 1:1000:mouse
monoclonal, R&D Systems (R&D Systems Europe Ltd, Abingdon, UK),
PP-H7147–00. Sections were visualized with Bond ‘Refine’ 3,3′-diaminoben-
zidine (DAB), counter-stained with haematoxylin. IgG-negative sections,
exposed to non-immune mouse and rabbit or goat serum in the absence of
primary antibody, were included in all runs and showed no positive immunos-
taining. Human fetal ovarian localization for cytochrome P450 scc (CYP11A1)
and homeobox protein NOBOX (NOBOX) have previously been reported
(e.g. (Huntriss et al., 2006; Fowler et al., 2011)).
Ovaries from ten 17- to 19-week-old fetuses (five control, five smoke-
exposed, for details see Supplementary data, Table SI) were scanned using
a Zeiss LSM700 and Zen Blue 2012 software and images captured with a
Zeiss Mrm camera and visually assessed by a single observer blinded to
group identity. The number of (i) primordial follicles and (ii) DDX4,
POU5F1 and MVP positive germ cells were determined in single sections
(2–4 sections in the case of MVP) and normalized relative to the total area
of the relevant sections using ImageJ software.
Western blot
Proteinswere extracted from fetal ovarieswithQiagenAllPrepDNA/RNA/
Protein mini kits (Qiagen Ltd, Crawley, UK). Tissue was homogenized in the
presence of protease inhibitors (Protease Inhibitor Cocktail, Sigma-Aldrich
Company Ltd, Gillingham, UK). Proteins (30 mg/lane) and Odyssey Two-
Color molecular weight markers (LI-COR Biosciences UK Ltd, Cambridge,
UK) were electrophoresed on a single dimension, 4–12% Bis-Tris gels (Invi-
trogen Ltd, Paisley, UK) under reducing conditions and transferred to
immobilon-FL membranes (Millipore (UK) Ltd, Watford, UK). Membranes
were blocked with Odyssey Blocking Buffer (927–4000: LICor) and incu-
bated with primary antibodies: (i) steroid sulfatase (microsomal), isozyme
S (STS): 1:500: rabbit polyclonal, Sigma-Aldrich Company Ltd, Poole, UK,
HPA002904, (ii) G protein-coupled estrogen receptor 1 (GPER): 1:1000:
rabbit polyclonal, Sigma-Aldrich Company Ltd, HPA027052, (iii) MVP:
2 mg/ml: mouse monoclonal, Abcam, ab14562, (vi) NR2F1: 1:500: rabbit
polyclonal, Abcam, ab96846. Protein bands were visualized using an
Odyssey infrared fluorescence imager (LI-COR) and analysed using TotalLab
TL120 software (v2008.1; Nonlinear Dynamics Ltd, Newcastle upon Tyne,
UK) (see (O’Shaughnessy et al., 2011)).
Ovarian estrogen production
Three human fetal ovaries from control fetuses (Table I) were dissected free
of other tissues, and then cut longitudinally and transversely. Tissue pieces
were placed on cell culture inserts (PICM ORG 50, Millipore UK Ltd), each
well receiving half an ovary. The cells contained 1 ml Waymouth media
(Fisher Scientific UK Ltd, Loughborough, UK) supplemented with ITS+
(BD Biosciences), penicillin/streptomycin (Sigma-Aldrich), pyruvic acid
(Merck) and follistatin (0.4 mg/ml, R&D Systems Europe Ltd, Abingdon,
UK). Fetal ovary pieces were cultured at 378C in 5% C02 and the media
was replaced every 48 h. Culture medium representing 1–48 and 49–72 h
culture periods were used for estrogen assay.
.................................................
.............................................................................................................................................................................................
Table III Concentrations of PAHs in the human female fetal liver (mg/kg tissue weight, mean+ SEM, based on the qPCR/
PAH group shown in Table I).
PAH name PAH Control Smoke-exposed Two-way ANOVAc
n 5 8a n 5 8a Smoke Weeks-smoke
Acenaphthene AC 0.16+0.08 5.67+4.54 0.809 0.165
Benzo[ghl]perylene BghlP 0.46+0.30 0.67+0.67 0.620 0.732
Fluoranthene FA 1.73+1.73 7.29+7.08 0.659 0.295
Fluorene FL 6.48+2.83 72.8+38.8 0.021 0.128
Phenanthren PHE 13.7+4.18 89.1+47.5 0.025 0.112
Naphthalene NA 7.44+1.13 16.9+10.4 0.807 0.097
Bezo[b]fluoranthene BbF 0.83+0.83 1.07+1.02 0.947 0.168
Anthracene AN 1.32+0.92 19.0+6.71 0.999 0.277
Pyrene PY ,LODb 11.37+6.77 0.044 0.099
Benzo[k]fluoranthene BkF ,LODb 1.00+0.86 0.175 0.744
Benzo[a]pyrene BaP ,LODb 1.37+1.37 0.388 0.518
Benzo[a]anthracene BaA 1.42+0.59 1.43+0.62 0.966 0.129
Chrysene CHR 3.56+3.21 0.01+0.01 0.352 0.670
Acenaphthalene ACL 0.45+0.44 ,LODb 0.809 0.165
Total 37.6+4.3 216.3+123.5 0.011 0.018
aSome livers were pooled to ensure sufficient material for analysis, n above refers to either separate or pooled livers used for each group from the same fetuses used for qPCR.
bPAHs, limits of detection (,LOD) in all livers, excluded from analysis.
cStatistically significant P-values are shown in bold, italicized for ANOVA results using LOD values for ,LOD PAHs. Weeks-smoke ¼ two-way ANOVA interaction between weeks of
gestation and smoke exposure.
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PAH determinations
The fetal liver concentrations of 16 PAHs known to be in cigarette smoke
were determined as previously described (Fowler et al., 2008). Briefly,
seven internal standards (0.05 mg) were added to freeze-dried livers and
PAHs extracted and quantified using GC/MS operated in the single ion-
monitoring mode (Thermo Electron Trace MS (Hemel Hempstead, UK)
linked to a Trace 2000 GC fitted with an AS2000 auto-sampler).
Real-time quantitative PCR (qPCR,
Supplementary data, Table SII)
Forquantification of specificmRNAspecies in fetal ovaries (see (Fowler et al.,
2009a,b, 2011)), qPCRwas used after reverse transcription of isolated RNA
(see (O’Shaughnessy et al., 2007)). To allow specific mRNA levels to be
expressed per ovary, 5 ng external standard (luciferase mRNA: Promega
UK, Southampton, UK) was added to each ovary at the start of the RNA
Figure 1 The estrogen and inhibin/activin signalling systems in human fetus and ovary are affected by maternal smoking. (A) In utero smoke exposure
increases circulating fetal estrogen during the late second trimester (estrone [E1] predominates) although the E1/estradiol [E2] ratio is not significantly
different between groups. (B) The fetal human ovary (from control fetuses) itself produces significant quantities of E2 and E1 in vitro (E2 predominates,
P ¼ 0.016). Values for the first 48 h of culture are shown, but were very similar during the second 48 h of culture. (C) The human fetal ovary expresses
higher levels of estrogen receptor b (ESR2) isoforms a and d (ESR2 +ve: values were calculated as isoforms b and c subtracted from total ESR2) than
the dominant-negative isoforms b and c (ESR2 –ve). Although these are not significantly affected by maternal smoking, the ratio between the two
shows a significantly different variance (Levene’s test P ¼ 0.022) with 5/12 smoke-exposed fetuses deviating from the control range. (D) Transcripts
for the putative non-nuclear estrogen receptor G-protein-coupled estrogen receptor 1 (GPER) are expressed in fewer than half the ovaries examined
and only very low levels of protein could be detected. (E) The fetal human ovary expresses increasing STS transcript across the second trimester and
also expresses the mature protein. (F) Smoke exposure skews the Inhibin bA/inhibin a (INHBA:INHA) transcript expression ratio in favour of activin A.
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extraction (Baker and O’Shaughnessy, 2001). Ovarian RNA was extracted
using TRIzol (Life Technologies, Paisley, UK). The real-time PCR approach
utilized the SYBR green method using a Stratagene MX3000 cycler. The
quantity of each measured cDNA from the real-time PCR was expressed
relative to the standard luciferase cDNA in the same sample. Transcripts
were selected from our own gene array study of primordial follicle formation
(Fowler et al., 2009a) and from the literature.
Data analysis
Statistical analysesof datawereperformedusing JMP9.0.2 software (Thomas
Learning, London, UK). Normality of data distribution was tested with the
Shapiro–Wilk test and non-normally distributed data were log-transformed
and re-checked for normality prior to analysis by analysis of variance
(ANOVA) and Tukey-Kramer honest significant difference test. Care was
taken to ensure that groups were balanced in terms of fetal age. Because
most of the parameters investigated showed developmental changes in ex-
pression across the second trimester, two-way ANOVA was used to test
the combined effects of gestational age (weeks) and maternal smoking
(yes/no) on morphological and biochemical data and gene expression
levels. A statistically significant increase in variation in the smoke-exposed
group and a reduced correlation between transcript levels and weeks of ges-
tation (two-way ANOVA: interaction between smoking and weeks of gesta-
tion, P, 0.05) was observed for four transcripts. This statistically significant
disturbance of transcript expression patterns across the second trimester is
described as dysregulation. Levene’s test was used to probe the significance
of differences in variances between control and smoke-exposed groups.
Bioinformatics
Following on from our previous study (Anderson et al., 2014) showing AHR
expression in the late first and second trimester human fetal ovary and
AHR-induced reduction in late first trimester human fetal ovary, we utilized
a combined literature search and IPA pathway analysis strategy to look for
further AHR target genes. Data mining and bioinformatics were carried
out using the University of California and Santa Cruz (UCSC) genome
browser (http://genome.ucsc.edu/index.html). Analysis was carried out
using the Human Mar. 2006 (NCBI36/hg18) assembly. Highlighted binding
sites have been conserved between humans and rodents (75 million years
of divergent evolution) and calculated using the Transfac Matrix Database
(v7.0) set at its most stringent setting (Z score cut-off ¼ 2.33).
Results
Maternal cigarette smoking does not
significantly affect gross female fetal
morphology
There were no significant morphological differences between control
and smoke-exposed groups and no statistically significant interaction
Figure 2 Circulating gonadotrophins in the human fetus are not affected by maternal smoking although fetal ovarian FSH receptor expression is dis-
turbed. (A) Circulating fetal LH and FSH increase significantly across the second trimester. (B) Circulating fetal PRL is variable, showing no significant
pattern while intact hCG in the fetal circulation declines sharply between 11 and 21 weeks of gestation. However expression of the FSHR is affected by
maternal smoking with the significant increase in FSH receptor (FSHR) transcript expression across the second trimester in control fetal ovaries (C) abol-
ishedbymaternal smoking (D).Data are shownasmean+ SEMand P-values arederived fromone-wayANOVAfordifferences inmeans. In (A) and (B), the
data arederived fromthe45 fetusesof the Endocrine group shown inTable I. In (C) and (D), linear regression fits (basedon the22 fetusesof theqPCR/PAH
group shown in Table I) are shown by solid (control) or dashed (smoke-exposed) lines and 95% confidence limits by solid (control) and stippled
(smoke-exposed) shading.
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between weeks of gestation and maternal cigarette smoking (Table I).
Neither fetal cotinine, nor cigarettes smoked per day (reported by
the mother), correlated significantly with fetal weight (r ¼ 0.106,
P ¼ 0.301; r ¼ 20.063, P ¼ 0.563, respectively) or crown-rump
length (r ¼ 0.160, P ¼ 0.191; r ¼ 20.042, P ¼ 0.70, respectively)
or ovary weight (r ¼ 20.001, P ¼ 0.991; r ¼ 20.040, P ¼ 0.711,
respectively).
Maternal cigarette smoking disturbs female
fetal endocrine signalling
Both estrone (E1) and estradiol (E2) concentrationswere extremely high
in the fetal circulation andwere further increased (2- to 3-fold) bymater-
nal smoking (Fig. 1A, Table I). In cultured ovaries (Fig. 1B) of fetuses
from non-smoking women, E1 release was significantly less than E2
release, with an E1:E2 ratio (0.35+0.11) much lower than that in the
fetal circulation, where E1 was dominant (E1:E2 ratio ¼ 2.0 in control
and 2.9 in smoke-exposed fetuses). Mean levels of transcripts encoding
the estrogen receptor 2 (ESR2) were not affected by maternal smoking
(Table II) but separate analysis of active and dominant-negative ESR2
isoform transcripts (Table II, Fig. 1C) showed that maternal smoking
altered the ratio of active/dominant negative transcripts so that variance
was significantly altered (Levene’s test, P ¼ 0.022). Within the
smoke-exposed group, five fetuses showed a marked shift in balance
between the two types of isoforms, favouring expression of transcripts
encoding the active receptor isoform. Putative estrogen detection may
also occur throughGPER, althoughmost ovaries did not have detectable
levels of transcripts (Fig. 1D, Table II). Expression of STS (Fig. 1E) in the
fetal ovary increased across the second trimester showing that the ovary
can probably de-conjugate estrogens although there was no effect of
maternal smoking (Table II). Maternal smoking was, however, associated
with a significant 1.7-fold increase in the intra-ovarian InhibinbA/inhibina
ratio (INHBA/INHA) transcript ratio (Fig. 1F), which would tend to shift
the balance from inhibin towards activin signalling.
Circulating LH and FSH (Fig. 2A) significantly increased across the
second trimester but PRL (Fig. 2B) showed no trend and intact hCG
decreased (Fig. 2B). Maternal smoking did not significantly affect fetal
LH, FSH, PRL or hCG (Table I) or endocrine receptor transcripts
(Tables I and II). The statistically significant increase in FSH receptor
(FSHR) across the second trimester seen in control ovaries (Fig. 2C)
was, however, not observed in smoke-exposed ovaries (Fig. 2D).
Maternal cigarette smoking disturbs oocyte/
follicle progression in the second trimester
human fetal ovary
In ovaries from fetuses averaging 18weeks of gestation (see Supplemen-
tary data, Table SII) therewas an increase in primordial follicle number in
smoke-exposed fetuses (Fig. 3A). In the same group there was also an
increase inDDX4+ve oocyte number although therewas no smoke ex-
posure effect on the numbers of POU5F1+ve oocytes between the two
groups (Fig. 3C). MVP in the human fetal ovary is oocyte-specific and
both MVP transcript and protein increased markedly across the
second trimester (13.4-fold from 11–3 to 17–21 weeks of gestation:
Fig. 3E and F). However, transcript levels and the number of MVP+ve
oocytes were not significantly affected by maternal smoking (Table II,
Fig. 3G).
Maternal cigarette smoking dysregulates key
fetal ovarian transcripts
Most of the 58 ovarian transcripts investigated (Table II) showed no
statistically significant effect of maternal smoking (e.g. follistatin
[FST]). Considerable inter-fetus variation precluded statistical sig-
nificance for some transcripts with large differences between
means (e.g. POU5F1). Four fetal ovarian transcripts (cytochrome
P450 scc [CYP11A1], homeobox protein NOBOX [NOBOX], HRK,
NR2E1), however, showed significant dysregulation with smoke expos-
ure (Fig. 4). The dysregulation manifested as a statistically significant
increase in variation in the smoke-exposed group and a reduced cor-
relation between transcript levels and weeks of gestation (2-way
ANOVA: interaction between smoking and weeks of gestation,
P, 0.05). No statistically significant dysregulation was observed for
other ovarian transcripts or any other measures from either
the whole population or subpopulations detailed in Table I (e.g.
body weight, hormone profiles). This indicates that the smoke
exposure-associated disturbance of these four transcripts is not
due to sample selection or effects on fetal growth rates. NR2E1
ovarian transcript levels (Fig. 4E) were also significantly higher in
smoke-exposed fetuses ,16 weeks old. NR2E1 protein was localized
to somatic cell nuclei and was absent from most germ cells. Most
pre-granulosa cells in primordial follicles showed strong NR2E1 stain-
ing, which was also seen in many somatic cells around nests. Mesen-
chymal cell streams were mostly NR2E1 negative (Fig. 4F). HRK
protein was localized to scattered germ cells, especially those in
nests while those enclosed in primordial follicles were mostly
HRK-negative (Fig. 4D).
Maternal cigarette smoking increases female
fetal liver PAH content
Overall liver PAHswere significantly higher in smoke-exposed livers than
control livers (5.8-fold, P ¼ 0.011, Table III). Pyrene, benzo[k]fluor-
anthene and benzo[a]pyrene were only detectable in smoke-exposed
fetuses while acenaphthalene was detectable only in controls. Ben-
zo[a]anthracene concentrations showed no change as a result of mater-
nal smoking,while chrysenewas323-fold higher in control livers although
extremely variable between fetuses. Of the 10 PAHs that were detect-
able in both groups, 8 were between 1.3-fold and 35.8-fold higher in
smoke-exposed fetuses, although only fluorene (11.2-fold, P ¼ 0.021)
and phenanthrene (6.5-fold, P ¼ 0.025) reached statistical significance.
NR2F1, an AHR target gene, is a candidate
mediator the effects of maternal smoking on
the fetal ovary
Fifteen AHR target genes were further investigated, based on known or
possible roles in ovarian development and xenochemical detection
or metabolism (Table IV). NR2F1 was significantly dysregulated
(P ¼ 0.021) and increased (P ¼ 0.026) in smoke-exposed fetuses
(Fig. 5A, Table IV). The closely relatedNR2F2was not affected bymater-
nal smoking (Fig. 5B). Expression of NR2F2 was nuclear in ovarian
somatic cells and testis Leydig and peritubular myoid cells (labelled
inset, Fig. 5C and D), but the protein was also located in the cytoplasm
of some oocytes earlier in gestation and then also in the nuclei of some
oocytes at later stages. The major band recognized by the NR2F1
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Figure 3 Maternal cigarette smoking affects fetal human ovarian germ cell development at 17–21weeks of gestation. Smoke-exposed fetal ovaries have a
higher density of primordial follicles (A,B) aswell as an increased density ofDEADbox protein 4 (DDX4)+ve oocytes (C). In contrast, neither POUdomain,
class 1, transcription factor 1 (POU5F1)+ve (C) normajor vault protein (MVP)+ve (G) oocyte densitieswere affected bymaternal smoking.MVPexpression
increases sharply across the second trimester (E, F). MVP was localized to oocyte cytoplasm (F, G) although expression prior to 17–21 weeks was very in-
frequent and faint. Evenat 19weeks and later thereweremanyMVP-veoocytes visible. In (D), (F) and (G), the stain isDAB (brown)and counterstain is haema-
toxylin, visualized by brightfield view. The inset panels show the absence of staining in IgG-negative (non-immune serum) controls. In (B) the black arrow
highlights a primordial follicle, the white arrow a mesenchymal cell stream and the grey arrow an oocyte nest while in (D), (F) and (G), black arrows
denote +ve staining, white arrows –ve stain.
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antibody on a western blot (Fig. 5D) was at 46 kDa as expected. Of the
other two major xenosensors, nuclear receptor subfamily 1 group I
member 2 (NR1I2 [PXR]) transcript was detected in most ovaries and
unaffected by maternal smoking while nuclear receptor subfamily 1
group I member 3 (NR1I3 [CAR] was detected in a high proportion of
control ovaries (Fig. 5E, Table IV).
Figure4 In utero smoke exposure dysregulates expression of key ovarian transcripts. Dysregulation is defined as a statistically significant increase in vari-
ation in the smoke-exposed group and a reduced correlation between transcript levels and weeks of gestation (assessed by two-way ANOVA: interaction
between smoking and weeks of gestation, P, 0.05): (A) cytochrome P450 scc [CYP11A1] (controls: log CYP11A1 ¼ 26.03 + 0.47*weeks, P, 0.001;
smoke-exposed: log CYP11A1 ¼ 22.65 + 0.25*weeks, P ¼ 0.013), (B) homeobox protein NOBOX [NOBOX] (controls: log NOBOX ¼ 220.28 -
+ 1.30*weeks, P, 0.001; smoke-exposed: log NOBOX ¼ 211.49 + 0.78*weeks, P ¼ 0.013), (C) activator of apoptosis harakiri [HRK] (controls: log
HRK ¼ 25.71 + 0.38*weeks, P, 0.001; smoke-exposed: log HRK ¼ 22.13 + 0.17*weeks, P ¼ 0.021), (E) nuclear receptor subfamily 2 group E
member 1 [NR2E1] dysregulation (controls: log NR2E1 ¼ 2.05 + 0.18*weeks, P ¼ 0.008; smoke-exposed: log NR2E1 ¼ 2.28 + 0.16*weeks,
P ¼ 0.022) is very similar to that shown for HRK and therefore not shown. However, younger fetuses demonstrate clear smoke-induction of NR2E1,
with histograms and error bars denoting mean+ SEM. In (A)–(C) linear regression fits are shown by solid (control) or dashed (smoke-exposed) lines
and 95% confidence limits by solid (control) and stippled (smoke-exposed) shading. Controls are shown by white circles/bars, smoke-exposed by grey
circles/bars. (D) HRK was localized to scattered germ cells while most germ cells in primordial follicles were HRK-negative. HRK was also localized in
some somatic cells, especially pre-granulosa cells associated with primordial follicles (inset). (F) NR2E1 was localized to somatic cell nuclei and absent
from germ cells. Most pre-granulosa cells in primordial follicles showed strong NR2E1 staining as did many somatic cells around nests. In (D) and (F)
the stain is DAB (brown) and counterstain is haematoxylin, visualized by brightfield view. The inset panels show the absence of staining in IgG-negative
(non-immune serum) controls. Black arrows denote +ve staining, white arrows –ve stain.
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We also interrogated the UCSC Genome Bioinformatics Website to
trawl for AHR-related transcription factor binding sites (Table V) and
found that of the maternal-smoking dysregulated genes CYP11A1 had a
conserved AHR/ARNT binding site, as did FSHR and NR2F1. Further-
more, NR2E1, CYP11A1 and FSHR all had NR2F1 binding sites.
Discussion
This extensive study shows thatexposure to the complexmixtureof che-
micals in cigarette smoke disturbs human fetal ovarian development in
uteroand increases the fetal burdenofAHR-activating chemicals. The sig-
nificance of this is highlighted by our demonstration that in vitro activation
of AHR reduces human fetal ovarian germ cell proliferation. We also
show that the female human fetus is normally exposed to very high
levels of endogenous estrogens, which markedly increase if the mother
smokes. Overall, our findings suggest, for the first time, that prenatal
maternal cigarette smoking induces AHR activation, dysregulates genes
important in ovarian development (including inhibin/activin and FSH
signalling), reduces germ cell proliferation and elevates estrogen expos-
ure in the human. We propose that these changes probably contribute
significantly to the observed reduced fecundity in women exposed to
cigarettes prenatally (Ye et al., 2010).
Our data on maternal smoking effects on primordial follicle number
and number of DDX but not POU5F1 positive oocytes clearly support
the conclusion that primordial follicle formation is dysregulated in
smoke-exposed fetuses. Nevertheless, the relatively small sample size
of five ovaries/group and low number of primordial follicles in the popu-
lation available means that this finding needs to be confirmed in a larger
study, especially one using full stereological techniques to count oocytes
and follicles. However, it must be noted that the data are internally con-
sistent with increased primordial follicle number associated with
increasedDDX4 positive oocytes, whichwould be expected (Anderson
et al., 2007). Previous studies suggest that cigarette smoke PAHs, which
are AHR ligands, disturb ovarian development (Jurisicova et al., 2007;
Tuttle et al., 2009) and here we report significantly increased PAH con-
centrations in livers of female fetuses exposed to maternal cigarettes.
Numerous reports exist of adverse effects of AHR ligands on reproduct-
ive development and function (e.g. (Coutts et al., 2007; Sobinoff et al.,
2011)) and the trend for dysregulated AHR:ARNT transcript ratios in
the smoke-exposed fetal ovaries (Table II, P ¼ 0.057) suggests alteration
inAHRsignalling. Further studies are required, however, to relate agonist
bioactivity to levels in human fetuses. In the female human fetus, cigarette
exposure is linked to decreased germ cell and somatic cell numbers
(Lutterodt et al., 2009; Mamsen et al., 2010). Furthermore, the
reduced germ cell proliferation we previously reported in fetal ovaries
....................................................
.............................................................................................................................................................................................
Table IV Effects of maternal cigarette smoking on the mRNA transcript levels of selected AHR responsive/target genes
and/or matching binding sites on genes identified in Table II and Fig. 4 as dysregulated by maternal smoking (cytochrome
P450 scc [CYP11A1], NOBOX oogenesis homeobox [NOBOX], activator of apoptosis harakiri [HRK], nuclear receptor
subfamily 2, group E, member 1 [NR2E1]) in the human female fetal ovary (mean+ SEM, based on the qPCR/ PAH group
shown in Tables I and II).
Gene
symbol
Gene product Controla Smoke-exposeda Two-way ANOVA
Smoking Weeks–smoke
interaction
n5 10 n 5 12 Pb Pb
1. UGT1A UDP-glucuronosyltransferase 1-1 0.032+0.013 0.033+0.015 0.975 0.970
2. NQO1 NAD(P)H dehydrogenase [quinone] 1 1.772+0.442 1.650+0.476 0.384 0.191
3. ESRRG Estrogen-related receptor gamma 1.920+0.462 1.903+0.523 0.923 0.399
4. CTNNB1 Catenin beta-1 166.9+53.74 121.6+34.00 0.667 0.222
5. CDKN1B Cyclin-dependent kinase inhibitor 1B (p27Kip1) 22.56+8.702 16.73+5.942 0.365 0.423
6. SMAD4 Mothers against decapentaplegic homolog 4 64.50+19.70 59.69+18.67 0.936 0.351
7. POR NADPH–cytochrome P450 reductase 9.768+2.723 8.800+2.266 0.825 0.281
8. CYP1A1 Cytochrome P450 1A1 0.115+0.045 0.076+0.022 0.743 0.656
9. CARc Nuclear receptor subfamily 1 group I member 3
(NR1I3)
0.075+0.041 0.005+0.005 0.031c NA
10. PXR Nuclear receptor subfamily 1 group I member 2
(NR1I2)
0.269+0.084 0.257+0.087 0.650 0.799
11.NR2F1 COUP transcription factor 1 7.375+ 2.544 8.467+ 1.843 0.026 0.021
12. NR2F2 COUP transcription factor 2 153.1+30.06 131.1+26.54 0.613 0.789
13. REST RE1-silencing transcription factor (NRSF) 76.69+20.87 65.52+19.97 0.802 0.344
14. FOXP3 Forkhead box protein P3 2.263+0.917 1.235+0.448 0.406 0.444
15.MYC Myc proto-oncogene protein 22.75+6.007 19.46+3.975 0.872 0.307
aqPCR is expressed as mRNA relative to luciferase.
bStatistically significant P-values are shown in bold. Where relevant, multi-function genes are categorized according to their function most appropriate to ovarian development.
cTranscript expression below limit of detection in ≥50% of ovaries.
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Figure 5 Maternal smoking dysregulates COUP transcription factor 1 (NR2F1 [COUP-TF1]) but not COUP transcription factor 2 (NR2F2 [COUP-TF2])
expression in the fetal ovary.Dysregulation is defined as a statistically significant increase in variation in the smoke-exposed group and a reduced correlation
between transcript levels and weeks of gestation (assessed by two-way ANOVA: interaction between smoking and weeks of gestation, P, 0.05): (A)
NR2F1 (controls: log NR2F1 ¼ 25.35 + 0.43*weeks, P ¼ 0.006; smoke-exposed: log NR2F1 ¼ 0.33 + 0.11*weeks, P ¼ 0.147), (B) NR2F2 (controls:
log NR2F2 ¼ 2.05 + 0.18*weeks, P ¼ 0.008; smoke-exposed: log NR2F2 ¼ 2.28 + 0.16*weeks, P ¼ 0.022). In (A) and (B) linear regression fits are
shown by solid (control) or dashed (smoke-exposed) lines and 95% confidence limits by solid (control) and stippled (smoke-exposed) shading. Controls
are shown by white circles/bars, smoke-exposed by grey circles/bars. NR2F1 was localized (C) to the cytoplasm of some oocytes and the nuclei of scat-
tered somatic cells earlier in the second trimester but later was also expressed in the nuclei of some oocytes and in some somatic cells, including some
pre-granulosa cells. Many mesenchymal cell streams were NR2F1 2ve. In the testis NR2F1 was localized predominantly to Leydig cell nuclei. NR2F2
(D) was localized to the nuclei of many somatic cells, including mesenchymal cell stream nuclei, and also to smaller oocytes. NR2F2 was also localized
in some pre-granulosa cell nuclei and predominantly in Leydig and peritubular myoid cell nuclei in the testis. In (C) and (D) the stain is DAB (brown)
and counterstain is haematoxylin, visualized by brightfield view.The inset panels show the absence of staining in IgG-negative (non-immune serum) controls
or, if labelled ‘Testis’, showmatching expression in the second trimester human fetal testis. Black arrows denote+ve staining, white arrows –ve stain. The
xenosensor nuclear receptor subfamily 1 group I member 2 (NR1I2 [PXR]) (E) was detectable in most ovaries examined but was not affected by maternal
smoking. In contrast the xenosensor nuclear receptor subfamily 1 group I member 3 (NR1I3 [CAR]) (E) was detectable in few ovaries and was significantly
reduced by maternal smoking.
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cultured with an AHR-activating ligand (Anderson et al., 2014) would be
a key component in disturbing the germ/somatic cell balance that under-
pins appropriate primordial follicle formation in the developing ovary.
Levels of fetal circulating estrogens measured in the present study
were very high and markedly greater than those reported previously
(Shutt et al., 1974; Smith et al., 1975). The reason for this discrepancy
is not clear but the early studies used an indirect competitive protein
binding assaymethod that does not give information on the analyte iden-
tity. In their detailed review of more recent studies Kuijper et al. (2013)
assembled data from a number of studies reporting similarly high female
fetal estrone and estradiol levels, supporting our findings reported here.
The fetal estrogen levels reported here are also markedly higher than
those in the maternal circulation (Holl et al., 2009). During pregnancy
the placenta is the main source of estrogens and differences between
fetal and maternal estrogen levels are probably due to concentration
effects of placental estrogens passing into the much smaller fetal blood
volume. In pregnantwomen estrogen levels are decreased and androgen
levels are increased by smoking (Bernstein et al., 1989; Toriola et al.,
2011). The different response to smoking in the fetus is probably
related to altered steroid metabolism by the mother, placenta and
fetus. Increased fetal estrogen is likely to be due to increased placental
production, conjugation and protein binding in the fetus. In addition,
human fetal ovarian and hepatic cytochrome P450 aromatase
(CYP19A1) (Fowler et al., 2009a, 2011; O’Shaughnessy et al., 2013),
which converts androgen to estrogen, will probably contribute to ele-
vated estrogens in smoke-exposed fetuses. Our data shown here, com-
binedwith the steroidmachinery reported in Fowler et al. (2009a, 2011),
strongly suggest that the fetal ovary itself may be a major contributor to
intra-ovarian estrogen titres.
The increased INHBA:INHA sub-unit ratio in smoke-exposed ovaries
would be expected to increase activin A, which is expressed in germ
cells immediately prior to follicle formation (Martins da Silva et al.,
2004). Indeed, administration of activin to neonatal mice during the
period of nest breakdown and primordial follicle formation significantly
increases the number of primordial follicles formed (Bristol-Gould
et al., 2006). Activin A suppresses Kit ligand (KITLG) expression in adja-
cent somatic cells, part of the system regulating the timing of follicle for-
mation (Coutts et al., 2008;Childs andAnderson, 2009), thusproviding a
mechanism for an effect on subsequent female fertility. The absence of
changes in circulating gonadotrophins in female fetuses exposed to
maternal smoking agrees with male data (Fowler et al., 2008, 2009b),
although LH and FSH were higher in female than male fetuses (up to
4.8-fold, P, 0.001). The latter sex difference is likely to be due to nega-
tive feedback by testosterone in the male fetuses.
In many species E2 reduces primordial follicle formation but, in the
human, the fetal ovary can produce high levels of E2 (present study)
and primordial follicle formation occurs in the presence of high fetal
and maternal estrogen levels. In some model species, FSH is required
.............................................................................................................................................................................................
Table V Coordinates, DNAmethylation status, polymorphic status and location relative to coding sequence of predicted
highly conserved (vertebrates) transcription factor binding sites fromUCSC browser (NCB136/hg18).
Gene and coordinates Conserved TF
binding sites
Coordinates CpG Methyl SNP? Position 5′, 3′ coding or
intronic
NR2E1
chr6:108593955-108616706
NR2F1
(COUP-TF1)
chr6:108592946-108592959 No No No 1009 bp 5′ of NR2E1 TSS (may also
lie within Intron 5 of flanking OSTM1
gene). Nested within PPARG site
below.
PPARG chr6:108592942-108592962 No No No Overlaps COUP-1 above.
chr6:108593899-108593921 Yes ND rs2233486 At transcriptional start site of NR2E1
gene.
CYP11A1
chr15:72424166-72447134
AHR ARNT. chr15:72419098-7419113 Yes Yes No Exon 4 of CYP11A1 gene. 12 base
pairs from TCF11 binding site.
NR2F1
(COUP-TF1)
chr15:72412478-72412491 No No No 5068 bp of CYP11A1 gene or within
intron 16 of flanking CCDC33 gene.
NOBOX
chr7:143726972-143738253
PPARG chr7:143721185-143721207 No No No 5742 3′ of NOBOX gene
HRK
chr12:115783410-115803615
TAL1A and
TAL1B,
chr12:115801860-115801875 Yes No No Highly conserved non-coding region
in HRK intron 1
NRSF chr12:115803362-115803382 Yes Yes No HRK Exon 1
PAX6 and chr12:115805441-115805461 Yes Yes No Highly conserved region 5′ of HRK
TSS
TCF3 (E47) chr12:115803257-115803,71 Yes No Within Exon 1 of HRK gene
FSHR
chr2:49043779-49236657
NR2F1
(COUP-TF1)
chr2:48974670-48974683 No No No Overlaps PPARG and lies 69 kb from
FSHR 3′ end.
ARNT chr2:49235172-49235191 No No No Within highly conserved region 30 bp
from FSHR TSS
NR2F1
chr5:92944799-92955542
AHR/ARNT chr5:92955089-92955107 Yes Yes No Within Last Exon of NR2F1 gene.
NR2F1
(COUP-TF1)
chr5:92944637-92944650 No No No 149 bp from NR2F1 TSS within
PPARG site.
TF, transcription factor; CpG, site of DNA methylation in TF binding site; Methyl, CpG is methylated in cortical neurones derived from 57-year-old male; SNP, TF site contains a single
nucleotide polymorphism; TSS, transcriptional start site; UTR, untranslated region; ND, no data.
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for primordial follicle formation (e.g. hamsters (Roy and Albee, 2000;
Wang and Roy, 2004)) and the high levels of FSH in the female fetal cir-
culation reported here would be consistent with this mechanism in the
human. While circulating fetal FSH is unaffected by maternal smoking,
the pronounced trend for reduced FSHR expression (a similar effect of
smoking was reported in a study published in Polish for granulosa cell
FSHR in women (Josiak et al., 2006)) and lack of increasing FSHR expres-
sion with gestational age (Table II, Fig. 2C and D) suggests that adverse
effects of smoking on primordial follicle formation may occur via
altered FSH signalling. In hamsters, FSH-regulated, ovary-produced E2
is critical for germ and somatic cell survival and differentiation, thereby
underpinning primordial follicle formation, but this effect is lost when
E2 levels rise beyond a threshold (Wang and Roy, 2007). Since in utero
exposure of women to diethylstilbestrol (DES) is associated with an
increased risk of infertility and early menopause (Hoover et al., 2011),
high circulating and intra-ovarianestrogens, togetherwith a reducedpro-
portion of ovarian dominant-negative ESR2 isoforms (in nearly half of
smoke-exposed fetuses reported here), support the hypothesis that ex-
cessive estrogenic signalling will impair human fetal folliculogenesis. The
fetal baboon, like the human (Fowler et al., 2011), also expresses ESR2 in
fetal oocytes (Bocca et al., 2008) and, using experimental approaches im-
possible in the human, multiple roles of estrogen in the fetal baboon
ovary have been identified. These include the regulation of a-inhibin
(Billiar et al., 2003), folliculogenesis (Zachos et al., 2002; Billiar et al.,
2003; Pepe et al., 2006), FSHR expression and oocyte proliferation
(Zachos et al., 2003; Burch et al., 2009). Furthermore, estrogen depriv-
ation does not alter levels of mothers against decapentaplegic homolog
(SMAD)-transducing activin signalling, suggesting that estrogen regulates
fetal baboon folliculogenesis bymodulating the intra-ovarian activin:inhi-
bin ratio (Billiaret al., 2004). This is identical tooneof theeffects reported
here for maternal smoking: a significant alteration in activin:inhibin tran-
script ratio. Suchanalterationmight beexpected toexert negativeeffects
on human follicle formation (Coutts et al., 2008; Childs and Anderson,
2009). We had previously observed a decrease in MVP protein in fetal
sheep exposed to a complex cocktail of environmental chemicals (Bel-
lingham et al., 2013) and therefore investigated MVP in the human fetal
ovary. However, transcript levels and the number of MVP+ve oocytes
were not significantly affected by maternal smoking, suggesting differ-
ences in the affected ovarian pathways between the human and the
sheep model.
Smoke exposure dysregulated expression of four fetal ovarian tran-
scripts (CYP11A1, HRK, NR2E1, NOBOX), each of which may play a
role in normal follicle formation and development. Dysregulation of
CYP11A1 (which is localized in oocytes (Fowler et al., 2011)), for
example, suggests smoke exposure will affect ovarian steroidogenesis.
Similarly, PAH exposure negatively affects the primordial follicle pool in
mice by inducing HRK in the presence of apoptosis regulator Bax
(BAX) (Matikainen et al., 2001; Jurisicova et al., 2007) and HRK is
mostly expressed in the oocytes and pre-granulosa cells associated
with primordial follicles in the fetal human ovary. Dysregulation and
increased expression of the transcriptional repressor NR2E1 in
,16-week-old human fetal ovaries exposed to cigarettes (present
study) may be related to the induction of POU5F1 expression (transcript
levels nearly doubled bymaternal smoking, Table II) through activationof
AKT signalling (Chavali et al., 2011). This is important since the AHR
ligand 7,12-Dimethylbenz(a)anthracene (DMBA) causes ovotoxicity in
mice by activating PI3K/AKT and mTOR signalling pathways (Sobinoff
et al., 2011) and maintenance of POU5F1 in fetal germ cells would
disrupt primordial follicle formation (Anderson et al., 2007). Deficits in
the oocyte-specific transcript NOBOX leads to impaired somatic-germ
cell communication and somatic cell invasion during ovarian develop-
ment (Lechowska et al., 2011). Dysregulated NOBOX would be
expected, therefore, to contribute to impairedgermcell nestbreakdown
and thereby alter primordial follicle formation.
Dysregulation of the AHR-responsive transcription factorNR2F1 and
the presence of highly conserved AHR/ARNT and/or NR2F1 binding
sites on the genes for NR2E1, CYP11A1 and FSHR are highly suggestive
of adverse consequences of AHR activation on the human fetal ovary
through several pathways. Firstly, NR2F1 (and NR2F2) is a repressor of
FSHR in gonadal cells (Xing et al., 2002). The cytoplasmic as well as
nuclear expression of NR2F1 has previously been reported (Tang
et al., 2005). In contrast, the related transcription factor NR2F2, which
has been proposed as part of the mechanism leading to masculinization
disorders (van den Driesche et al., 2012), was unaffected in the human
fetal ovary. Dysregulated NR2F1 expression and AHR activation, as a
result of maternal smoking, may therefore contribute to the disconnec-
tion between gestational stage and FSHR expression. Secondly, the trend
towards increased NR2F1 may also disturb retinoic acid signalling
(Zhuang andGudas, 2008), with potential disruption of the coordination
ofmeiosis entry,which is important in the fetal ovary (Childs et al., 2011).
Lastly there is also evidence linking NR2E1, NR2F1, FSH and the devel-
opmental/transcription regulator B-cell CLL/lymphoma 11A (zinc
finger protein) (BCL11A), with the pathways considered important in
oocyte-granulosa cell interactions (Perlman et al., 2006; Chan et al.,
2013).
Based on a synthesis of our data and the supporting literature we
propose a model (Fig. 6) in which disturbed coordination of a complex
sequence of events from nest breakdown to primordial follicle forma-
tion, via several pathways, will impair ovarian development of some,
but not all, fetuses. Increased estrogen and activin signalling and
AHR-activating ligands (e.g. PAHs) and reduced FSH signalling would
be expected to alter the coordination of pathways leading to primordial
follicle formation. The disturbed balance between proliferation and
apoptosis is likely to contribute to reduced numbers of germ and
somatic cells and impact negatively on primordial follicle formation. Dys-
regulation of CYP11A1 would be expected to affect the pattern of ster-
oidogenesiswithin forming primordial follicles. Altered expression of the
somatic cell orphan receptor NR2E1 may increase transcription repres-
sion and activateAKT signalling prior to the start of primordial follicle for-
mation. At the same time, dysregulated expression of NOBOX and a
shift in the intra-ovarian inhibin/activin signalling balance in favour of
activin Awould probably disturb germ cell nest breakdown and the syn-
chronization of primordial follicle formation. Early inhibition of AMH by
elevated E2 might also disrupt the timing of primordial follicle formation
(Grynberg et al., 2012). The observation that maternal smoking alters
specific transcript levels in some individuals andnotothers is likely to con-
tribute to the changed incidence of reduced fertility: i.e. some individuals
are affected but not all. Finally, activation of the AHR might modulate
estrogen actions, potentially increasing anti-estrogenic effects of AHR
ligands in cigarette smoke through ESR2 mediation of ARNT
co-activation (Swedenborg and Pongratz, 2010). Overall, it is also
likely that altered NR2F1 plays an important role in these processes.
These hypotheses are based on a relatively large number of samples
but given the large individual variation in response to maternal
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Figure 6 Diagram summarizing dysregulation of fetal ovarian development and primordial follicle formation by maternal cigarette smoking. Increased
circulating estrogen in the presenceof high intra-ovarian estradiol (E2) and aryl hydrocarbon receptor (AHR) activationwould lead to reducedproliferation
and dysregulation of activator of apoptosis harakiri (HRK)-mediated apoptosis. Disturbed nuclear receptor subfamily 2 group E member 1 (NR2E1) and
COUP transcription factor 1 (NR2F1) may be expected to increase transcription repression and PI3K/ACT and mTOR signalling, especially prior to
16 weeks gestation. Dysregulated homeobox protein NOBOX (NOBOX) and FSH receptor (FSHR) is likely to affect germ cell nest breakdown while
dysregulated germ cell CYP11A1 may affect steroidogenesis. Increased activation of estrogen receptor b (ESR2) (partly by reduced relative dominant-
negative ESR2 isoforms in some smoke-exposed ovaries) may lower intra-ovarian anti-Mullerian hormone (AMH), which, together with a shift in
intra-ovarian inhibin/activin signalling towards activin, would desynchronize primordial follicle formation.
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smoking, they will need to be followed up by more detailed mechanistic
studies with greater power.
In summary, these data provide a possible mechanistic explanation of
howmaternal cigarette smokingmaynegatively impact thehuman female
fetus, explaining the link betweenmaternal smoking and reduced fecund-
ity in daughters. Maternal cigarette smoking during pregnancy causes sig-
nificant dysregulation of key fetal ovarian genes and endocrine signalling
during the second trimester, partly driven by an increase in the liver
burden of AHR-activating ligands, PAHs.
Supplementary data
Supplementarydata areavailable athttp://humrep.oxfordjournals.org/.
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